Rademikibart IV for Acute Asthma and COPD Exacerbation
Clinical trial NCT07705737 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07705737
- Sponsor
- Connect Biopharm LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2026-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.